SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8212004 - Saegis Pharmaceuticals Completes Exclusive License Agreement for AlzheimeJohn McCarthy-1/6/2004
8202004 - Required patient population to hit 1 billion in sales <pre> PatJohn McCarthy-1/6/2004
8192004 - Amyloid-ß peptide induces oligodendrocyte death by activating the neJohn McCarthy-1/6/2004
8182004 - GB Therapeutics' GT 1061, targeted to Alzheimer's disease, proceeJohn McCarthy-1/6/2004
8172003 - Various drugs in the pipeline for pain .... bioscorpio.comJohn McCarthy-1/5/2004
8162003 - Namenda - Continuing Medical Education ... University of Alabama .... &John McCarthy-1/5/2004
8152004 - Neuroscientists Pinpoint Midlife Crisis In Brain Circuitry As Key To BraiJohn McCarthy-1/5/2004
8142004 - MS Drug May Aid in Cocaine Addiction Fri Jan 2 08:11:06 2004 MS Drug MJohn McCarthy-1/4/2004
8132004 - AD Conferences Events 2004 | 2005 20-23 March 2004 16th Annual Public John McCarthy-1/4/2004
8122004 - WW AD - Currently there are an estimated 18 million people worldwide withJohn McCarthy-1/4/2004
8112004 - AD statistics on Long Island, New York <b>An estimated 135,000 inJohn McCarthy-1/4/2004
8102004 - AD Calendar alzheimers.orgJohn McCarthy-1/4/2004
8092004 - Ebixa sales forecast by various analysts for 2004 and 2005 translate.goJohn McCarthy-1/4/2004
8082004 - Lundbeck will file Ebixa for Mild to Moderate AD in 2004 ..... they antiJohn McCarthy-1/4/2004
8072003 - Ebixa status in ScotLand - December 2003 <b>Dementia in Scotland John McCarthy-1/4/2004
8062002 - SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. John McCarthy-1/4/2004
8052001 - Memantine and protein-97 (SAP97) mRNA 1: Pharmacol Toxicol. 2001 Feb;88John McCarthy-1/4/2004
8042003 - Role of NR2B-type NMDA receptors in selective neurodegeneration in HuntinJohn McCarthy-1/4/2004
8032003 - Avigen goes after Diabetic Neuropathy East Bay firms join pain therapy qJohn McCarthy-1/4/2004
8022003 - Similarities between AD and Down Syndrome Ivanhoe Newswire) -- ResearcJohn McCarthy-1/3/2004
8012004 - Mad cow vaccine hunt both urgent, unprecedented By Jeremy Manier TribuneJohn McCarthy-1/3/2004
8002003 - Ciphergen - Alzheimer's Study Presented Alzheimer's Study PresenJohn McCarthy-1/3/2004
7992004 - Dephosphorylation of microtubule-associated protein tau by protein phosphJohn McCarthy-1/3/2004
7982004 - Amyloid suppresses induction of genes critical for memory consolidation iJohn McCarthy-1/3/2004
7972003 - Derek Lowe speculates on how Memantine works in AD Tuesday, October 21, John McCarthy-1/2/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News